CHYLLIA DIXON: Open Payments
NPI 1174916472 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,240 in 251 payments from 21 companies in 2025. Trend: 2023 $921 · 2024 $4,595 · 2025 $12,240
Speaker / faculty: $7,000Food & beverage: $5,240
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $7,974 |
| Otsuka America Pharmaceutical, Inc. | 19 | $644 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $602 |
| Tris Pharma Inc | 27 | $534 |
| Corium, LLC | 23 | $526 |
| Vanda Pharmaceuticals Inc. | 14 | $406 |
| Lundbeck LLC | 19 | $226 |
| Teva Pharmaceuticals USA, Inc. | 11 | $208 |
| Axsome Therapeutics, Inc. | 12 | $204 |
| Alkermes, Inc. | 11 | $189 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Dyanavel XR, Azstarys, FANAPT, Auvelity, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
